Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT00049062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: gefitinib

Sponsor

The University of Texas Health Science Center at San Antonio